Description
Tirzepatide 5mg – Dual Incretin Therapy for Type 2 Diabetes & Weight Management
Tirzepatide 5mg is a cutting-edge, once-weekly injectable medication developed to improve blood glucose control and support weight loss in adults with type 2 diabetes. It works by activating both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors—mimicking natural incretin hormones that play a key role in glucose metabolism and appetite regulation.
Key Benefits:
-
Lowers A1C and improves blood glucose stability
-
Reduces appetite and promotes sustained weight loss
-
Enhances insulin sensitivity and metabolic function
-
Convenient once-weekly subcutaneous injection
Usage:
Tirzepatide 5mg should be administered under the supervision of a licensed healthcare professional. It is typically used alongside diet and exercise as part of a comprehensive diabetes care plan.
Important Note:
Not intended for individuals with type 1 diabetes or those experiencing diabetic ketoacidosis. Always consult with your physician before initiating treatment.
⚠️ For Research or Prescribed Use Only. Not for Unsupervised Consumption.